Wellington Management Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.5M | Buy |
|
|||||
|
2025
Q2 | $68.1M | Sell |
|
|||||
|
2025
Q1 | $88.7M | Sell |
|
|||||
|
2024
Q4 | $103M | Sell |
|
|||||
|
2024
Q3 | $231M | Sell |
|
|||||
|
2024
Q2 | $187M | Buy |
|
|||||
|
2024
Q1 | $191M | Sell |
|
|||||
|
2023
Q4 | $211M | Sell |
|
|||||
|
2023
Q3 | $185M | Buy |
|
|||||
|
2023
Q2 | $239M | Buy |
|
|||||
|
2023
Q1 | $205M | Sell |
|
|||||
|
2022
Q4 | $241M | Sell |
|
|||||
|
2022
Q3 | $250M | Buy |
|
|||||
|
2022
Q2 | $263M | Buy |
|
|||||
|
2022
Q1 | $245M | Buy |
|
|||||
|
2021
Q4 | $242M | Buy |
|
|||||
|
2021
Q3 | $226M | Buy |
|
|||||
|
2021
Q2 | $38.1M | Sell |
|
|||||
|
2021
Q1 | $72.8M | Sell |
|
|||||
|
2020
Q4 | $92.4M | Sell |
|
|||||
|
2020
Q3 | $61.9M | Buy |
|
|||||
|
2020
Q2 | $48M | Sell |
|
|||||
|
2020
Q1 | $37.2M | Sell |
|
|||||
|
2019
Q4 | $54.8M | Sell |
|
|||||
|
2019
Q3 | $139M | Sell |
|
|||||
|
2019
Q2 | $411M | Buy |
|
|||||
|
2019
Q1 | $443M | Buy |
|
|||||
|
2018
Q4 | $261M | Buy |
|
|||||
|
2018
Q3 | $403M | Sell |
|
|||||
|
2018
Q2 | $468M | Sell |
|
|||||
|
2018
Q1 | $319M | Buy |
|
|||||
|
2017
Q4 | $272M | Buy |
|
|||||
|
2017
Q3 | $266M | Sell |
|
|||||
|
2017
Q2 | $326M | Buy |
|
|||||
|
2017
Q1 | $310M | Sell |
|
|||||
|
2016
Q4 | $369M | Buy |
|
|||||
|
2016
Q3 | $293M | Sell |
|
|||||
|
2016
Q2 | $205M | Buy |
|
|||||
|
2016
Q1 | $262M | Buy |
|
|||||
|
2015
Q4 | $258M | Buy |
|
|||||
|
2015
Q3 | $181M | Buy |
|
|||||
|
2015
Q2 | $171M | Buy |
|
|||||
|
2015
Q1 | $97.8M | Buy |
|
|||||
|
2014
Q4 | $60M | Buy |
|
|||||
|
2014
Q3 | $60.9M | Buy |
|
|||||
|
2014
Q2 | $28M | Sell |
|
|||||
|
2014
Q1 | $30.9M | Buy |
|